Analysts Expect Foamix (FOMX) Stock to Rise 532%; Rated Strong Buy


Foamix Pharmaceuticals (FOMX) stock has fallen -56.97% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives FOMX stock a score of 47 out of a possible 100.

That score is primarily influenced by a long-term technical score of 20. FOMX’s score also includes a short-term technical score of 33. The fundamental score for FOMX is 89. In addition to the average rating from Wall Street analysts, FOMX stock has a mean target price of $15.60. This means analysts expect the stock to climb 531.58% over the next 12 months.

Click Here to get the full Stock Score Report on Foamix Pharmaceuticals Ltd (FOMX).

What’s Happening with FOMX Stock Today

Foamix Pharmaceuticals Ltd (FOMX) stock has risen 15.42% while the S&P 500 has fallen -0.35% as of 10:38 AM on Tuesday, Jul 30. FOMX is up $0.33 from the previous closing price of $2.14 on volume of 2,814,703 shares. Over the past year the S&P 500 is up 7.41% while FOMX has fallen -56.97%. FOMX lost -$1.70 per share in the over the last 12 months.

Symbols: FOMX

You May Also Like